UCP2 and ovarian cancer: The analysis based on CCLE data suggested that some members of SLC25 family were highly expressed in breast, colorectal, stomach, liver, lung, and ovarian cancer cells, including SLC25A5, SLC25A6, and SLC25A8 (Figure 4(a)).